Cargando…
Cholinesterase inhibitor rivastigmine enhances nerve growth factor-induced neurite outgrowth in PC12 cells via sigma-1 and sigma-2 receptors
Rivastigmine (Riv) is a potent and selective cholinesterase (acetylcholinesterase, AChE and butyrylcholinesterase, BuChE) inhibitor developed for the treatment of Alzheimer’s disease (AD). To elucidate whether Riv causes neuronal differentiation, we examined its effect on nerve growth factor (NGF)-i...
Autores principales: | Terada, Kazuki, Migita, Keisuke, Matsushima, Yukari, Sugimoto, Yumi, Kamei, Chiaki, Matsumoto, Taichi, Mori, Masayoshi, Matsunaga, Kazuhisa, Takata, Jiro, Karube, Yoshiharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296549/ https://www.ncbi.nlm.nih.gov/pubmed/30557385 http://dx.doi.org/10.1371/journal.pone.0209250 |
Ejemplares similares
-
Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
por: Terada, Kazuki, et al.
Publicado: (2019) -
Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth in PC12 Cells by Ifenprodil: The Role of Sigma-1 and IP(3) Receptors
por: Ishima, Tamaki, et al.
Publicado: (2012) -
Discovery of N-cyclobutylaminoethoxyisoxazole derivatives as novel sigma-1 receptor ligands with neurite outgrowth efficacy in cells
por: Sun, Hao, et al.
Publicado: (2018) -
Neurite outgrowth in peripherin-depleted PC12 cells
Publicado: (1992) -
Inhibition of Nerve Growth Factor-Induced Neurite Outgrowth from PC12 Cells by Dexamethasone: Signaling Pathways through the Glucocorticoid Receptor and Phosphorylated Akt and ERK1/2
por: Terada, Kazuki, et al.
Publicado: (2014)